Join
Live feed
·
INSIDERFilingvia Quantisnow
Rubius Therapeutics Inc. logo

SEC Form 4: Appelhans Dannielle sold $1,323 worth of shares (10,385 units at $0.13), closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.
RUBY· Rubius Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RUBY (Rubius Therapeutics Inc.) and more on Quantisnow.